KR20040072534A - Production of fermented soy products containing germanium and selenium - Google Patents
Production of fermented soy products containing germanium and selenium Download PDFInfo
- Publication number
- KR20040072534A KR20040072534A KR1020040057011A KR20040057011A KR20040072534A KR 20040072534 A KR20040072534 A KR 20040072534A KR 1020040057011 A KR1020040057011 A KR 1020040057011A KR 20040057011 A KR20040057011 A KR 20040057011A KR 20040072534 A KR20040072534 A KR 20040072534A
- Authority
- KR
- South Korea
- Prior art keywords
- germanium
- selenium
- fruits
- plants
- vegetables
- Prior art date
Links
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 title claims abstract description 82
- 229910052732 germanium Inorganic materials 0.000 title claims abstract description 78
- 239000011669 selenium Substances 0.000 title claims abstract description 48
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 47
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 47
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 9
- 235000013311 vegetables Nutrition 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 5
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 5
- 229910003424 Na2SeO3 Inorganic materials 0.000 claims abstract description 4
- 235000018716 sodium selenate Nutrition 0.000 claims abstract description 4
- 239000011655 sodium selenate Substances 0.000 claims abstract description 4
- 235000015921 sodium selenite Nutrition 0.000 claims abstract description 4
- 239000011781 sodium selenite Substances 0.000 claims abstract description 4
- 235000013305 food Nutrition 0.000 claims description 20
- 241000196324 Embryophyta Species 0.000 claims description 17
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 235000021107 fermented food Nutrition 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims description 2
- 240000007124 Brassica oleracea Species 0.000 claims 6
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims 6
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims 4
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims 4
- 244000298479 Cichorium intybus Species 0.000 claims 4
- 235000007542 Cichorium intybus Nutrition 0.000 claims 4
- 241000219112 Cucumis Species 0.000 claims 4
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims 4
- 241000234282 Allium Species 0.000 claims 3
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims 3
- 241000332371 Abutilon x hybridum Species 0.000 claims 2
- 235000009434 Actinidia chinensis Nutrition 0.000 claims 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims 2
- 235000005254 Allium ampeloprasum Nutrition 0.000 claims 2
- 240000006108 Allium ampeloprasum Species 0.000 claims 2
- 240000007087 Apium graveolens Species 0.000 claims 2
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims 2
- 235000010591 Appio Nutrition 0.000 claims 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims 2
- 240000006891 Artemisia vulgaris Species 0.000 claims 2
- 235000000832 Ayote Nutrition 0.000 claims 2
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims 2
- 241000219198 Brassica Species 0.000 claims 2
- 235000003351 Brassica cretica Nutrition 0.000 claims 2
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims 2
- 244000221633 Brassica rapa subsp chinensis Species 0.000 claims 2
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 claims 2
- 235000003343 Brassica rupestris Nutrition 0.000 claims 2
- 244000025254 Cannabis sativa Species 0.000 claims 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims 2
- 235000002566 Capsicum Nutrition 0.000 claims 2
- 235000021538 Chard Nutrition 0.000 claims 2
- 240000008067 Cucumis sativus Species 0.000 claims 2
- 235000009849 Cucumis sativus Nutrition 0.000 claims 2
- 241000219122 Cucurbita Species 0.000 claims 2
- 235000009854 Cucurbita moschata Nutrition 0.000 claims 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims 2
- 240000009088 Fragaria x ananassa Species 0.000 claims 2
- 235000003228 Lactuca sativa Nutrition 0.000 claims 2
- 240000008415 Lactuca sativa Species 0.000 claims 2
- 244000021209 Leptospermum coriaceum Species 0.000 claims 2
- 235000015940 Leptospermum coriaceum Nutrition 0.000 claims 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims 2
- 244000070406 Malus silvestris Species 0.000 claims 2
- 240000004371 Panax ginseng Species 0.000 claims 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 2
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 2
- 241000758706 Piperaceae Species 0.000 claims 2
- 241000220324 Pyrus Species 0.000 claims 2
- 241000218201 Ranunculaceae Species 0.000 claims 2
- 240000007651 Rubus glaucus Species 0.000 claims 2
- 240000003768 Solanum lycopersicum Species 0.000 claims 2
- 244000269722 Thea sinensis Species 0.000 claims 2
- 235000006468 Thea sinensis Nutrition 0.000 claims 2
- 241000219094 Vitaceae Species 0.000 claims 2
- 235000021016 apples Nutrition 0.000 claims 2
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims 2
- 235000009120 camo Nutrition 0.000 claims 2
- 235000005607 chanvre indien Nutrition 0.000 claims 2
- 235000020971 citrus fruits Nutrition 0.000 claims 2
- 235000008434 ginseng Nutrition 0.000 claims 2
- 235000021021 grapes Nutrition 0.000 claims 2
- 239000011487 hemp Substances 0.000 claims 2
- 235000010460 mustard Nutrition 0.000 claims 2
- 235000021017 pears Nutrition 0.000 claims 2
- 235000015136 pumpkin Nutrition 0.000 claims 2
- 235000021013 raspberries Nutrition 0.000 claims 2
- 235000021012 strawberries Nutrition 0.000 claims 2
- 244000298715 Actinidia chinensis Species 0.000 claims 1
- 244000298697 Actinidia deliciosa Species 0.000 claims 1
- 240000002234 Allium sativum Species 0.000 claims 1
- 235000016068 Berberis vulgaris Nutrition 0.000 claims 1
- 241000335053 Beta vulgaris Species 0.000 claims 1
- 244000241235 Citrullus lanatus Species 0.000 claims 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 claims 1
- 235000002767 Daucus carota Nutrition 0.000 claims 1
- 244000000626 Daucus carota Species 0.000 claims 1
- 244000017020 Ipomoea batatas Species 0.000 claims 1
- 235000002678 Ipomoea batatas Nutrition 0.000 claims 1
- 244000088415 Raphanus sativus Species 0.000 claims 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims 1
- 244000061456 Solanum tuberosum Species 0.000 claims 1
- 235000002595 Solanum tuberosum Nutrition 0.000 claims 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims 1
- 235000013527 bean curd Nutrition 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- 235000012055 fruits and vegetables Nutrition 0.000 claims 1
- 235000004611 garlic Nutrition 0.000 claims 1
- 235000012015 potatoes Nutrition 0.000 claims 1
- 235000011649 selenium Nutrition 0.000 claims 1
- 230000032683 aging Effects 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 206010028980 Neoplasm Diseases 0.000 description 16
- 201000011510 cancer Diseases 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- 238000011160 research Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 235000011194 food seasoning agent Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 210000001539 phagocyte Anatomy 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 208000002177 Cataract Diseases 0.000 description 3
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 3
- 102000014150 Interferons Human genes 0.000 description 3
- 108010050904 Interferons Proteins 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 229940079322 interferon Drugs 0.000 description 3
- 150000002736 metal compounds Chemical class 0.000 description 3
- 231100000572 poisoning Toxicity 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 2
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000004531 blood pressure lowering effect Effects 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000020774 essential nutrients Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 231100000219 mutagenic Toxicity 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 102000009025 Endorphins Human genes 0.000 description 1
- 108010049140 Endorphins Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000001164 Osteoporotic Fractures Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- HTRSGQGJZWBDSW-UHFFFAOYSA-N [Ge].[Se] Chemical compound [Ge].[Se] HTRSGQGJZWBDSW-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 229910052800 carbon group element Inorganic materials 0.000 description 1
- 150000001724 carbon group elements Chemical class 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- -1 germanium Chemical class 0.000 description 1
- YBMRDBCBODYGJE-UHFFFAOYSA-N germanium oxide Inorganic materials O=[Ge]=O YBMRDBCBODYGJE-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 210000000003 hoof Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 239000002799 interferon inducing agent Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000005297 material degradation process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 125000000082 organogermanium group Chemical group 0.000 description 1
- PVADDRMAFCOOPC-UHFFFAOYSA-N oxogermanium Chemical compound [Ge]=O PVADDRMAFCOOPC-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000701 toxic element Toxicity 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/50—Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
Abstract
Description
본 발명은 게르마늄과 셀레늄이 함유된 장류식품제품의 제조방법에 관한 것으로,The present invention relates to a method for producing a food product containing germanium and selenium,
본 발명에 따라 제조되는 게르마늄-셀레늄함유 장류식품제품에는 인체에 독성이 없고 흡수율이 높은 유기 게르마늄과 셀레늄이 다량 함유되어 있어 식품으로서 섭취하여 현대인에게 부족한 자연치유물질인 게르마늄과 셀레늄 성분의 알려진 기능인 항산화력, 심장과 폐기능 향상, 노폐물질 분해, 간경화중 예방, 면역기능 향상, 성적기능 향상, 근이 영양증 치료, 항암 예방에 기여할 수 있다.The germanium-selenium-containing enteric food product manufactured according to the present invention contains a large amount of organic germanium and selenium, which are not toxic to the human body and have a high absorption rate, and thus are known as antioxidants of germanium and selenium, which are natural healing substances that are ingested as foods and lacked in modern people. History, heart and lung function, waste material degradation, liver cirrhosis prevention, immune function improvement, sexual function improvement, muscle nourishment treatment, anticancer prevention.
최근에는 원하는 영양소나 원소 또는 물질을 기존의 농축산물에 함유시켜 영양학적 부가가치를 높이려는 노력이 계속되고 있다. 그 대표적인 예가 유기 또는 무기상태의 게르마늄과 셀레늄을 식물에 비료로 공급하여 식물을 통해 다시 한번 유기화 과정을 거친 후 식물에 농축시켜 인체에 필요한 유효농도의 게르마늄과 셀레늄의 알려진 성분인 항암, 항산화 성분을 섭취하려하고 있으며, 또한 육류 및 유류 등의 축산물에서도 특정의 유용성분을 축적시키려는 시도가 있다.Recently, efforts have been made to increase nutritional added value by adding desired nutrients, elements or substances to existing agricultural products. A typical example of this is supplying organic or inorganic germanium and selenium as fertilizer to plants, and then organically processing through the plants, and then concentrating on the plants to obtain the effective concentrations of germanium and selenium, which are known components of the human body. There are also attempts to accumulate certain useful ingredients in livestock products such as meat and oil.
게르마늄은 주기율표 4B족에 속하는 탄소족원소의 하나. 원소기호 Ge, 원자번호 32, 원자량 72.59%로 먹는 산소로 알려져 있다.Germanium is one of the carbon group elements belonging to group 4B of the periodic table. It is known as the elemental symbol Ge, atomic number 32, and oxygen which is eaten at an atomic weight of 72.59%.
순도가 높은 유기게르마늄은 복용 후 인체 내에서 각종 임무를 마친 후 약 20-30시간 안에 인체 내에 있는 암 세포, 독소, 오염물질, 중금속 등을 붙들고 축적되는 것 없이 소변을 통해 인체에서 완전히 빠져나가므로 전혀 독성이 남지 않아 매우 안전하다.High-purity organic germanium completely escapes from the human body through urine without holding and accumulating cancer cells, toxins, contaminants, and heavy metals in the human body within about 20-30 hours after taking various tasks in the human body after taking them. It is very safe because there is no toxicity at all.
Source: Asai Germanium Research Institute, Tokyo, Japan.Source: Asai Germanium Research Institute, Tokyo, Japan.
동물실험 28일과 6개월 1mg/kg/Day 투여하며 정밀 관찰 결과 6개월 마지막에 수놈에게서 아주 약간의 무게가 줄어든 것 외에는 어떤 특별한 독성이나 중독 현상이 없었으며 동작이나 행동에도 이상이 발견되지 않았다. 뿐만 아니라 게르마늄은 복용하는 대로 소변을 따라 배출되기 때문에 6개월 후의 검사에서 어느 기관에서도 축적이나 중독 증상이 없었다.On the 28th and 6th month of the animal experiment, 1mg / kg / Day was administered and there was no specific toxicity or poisoning phenomenon except for the slight weight loss of the male at the end of the 6th month. In addition, because germanium is excreted in the urine as it is taken, there were no symptoms of accumulation or poisoning in any organ after 6 months of testing.
Source: Journal de Toxicologie Clinique et Experimental Dec. 11, 1991(7-8) 421-36-Source: Journal de Toxicologie Clinique et Experimental Dec. 11, 1991 (7-8) 421-36-
유기게르마늄(Ge-132)은 세포들의 부상(상해)을 예방Organo germanium (Ge-132) prevents injury to cells
게르마늄(Ge-132)의 상해(부상)를 입은 세포들에 대한 효과의 동물실험 연구에서 게르마늄(Ge-132)을 투여한 동물들의 세포들의 부상에 대한 예방과 스스로 치료되어지는 것을 발견하였다. 이 모든 효과들은 게르마늄(Ge-132)의 역할과 관련이 있다. 이러한 결과들은 게르마늄(Ge-132)이 세포들의 원활한 신진대사를 촉진하여 그것이 부상으로부터 보호되고 있는 것으로 보여진다.Animal studies of the effects of germanium (Ge-132) on injured (injury) cells have found that the treatment of the cells of germanium (Ge-132) -treated animals prevents and injuries themselves. All these effects are related to the role of germanium (Ge-132). These results show that germanium (Ge-132) promotes smooth metabolism of cells, which is protected from injury.
Source: Yao Hsueh Hsueh Pao Acta Pharmaceutica Sinica, 1992, 27(7):481-5Source: Yao Hsueh Hsueh Pao Acta Pharmaceutica Sinica, 1992, 27 (7): 481-5
만성 피로를 완화시켜 주는 개체로써의 게르마늄(Ge-132)Germanium as an Individual to Alleviate Chronic Fatigue (Ge-132)
게르마늄이 바이러스성의 만성피로 증후군(Chronic Epstein-Barr Virus Syndrome)의 증상을 약화시키고 완화시켜 준다는 사실이 발견되었다. 수백만의 미국인은 물론 세계 각국의 많은 사람들이 이 바이러스성의 만성피로 증후군(Chronic Epstein-Barr Virus Syndrome)으로 고통 받고 있다.Germanium has been found to attenuate and alleviate the symptoms of the Chronic Epstein-Barr Virus Syndrome. Millions of Americans, as well as many people around the world, suffer from this chronic Epstein-Barr Virus Syndrome.
Source: Use of Organic Germanium in Chronic Epstein-Barr Virus Syndrome,' Journal of Orthomolecular Medicine, 1989Source: Use of Organic Germanium in Chronic Epstein-Barr Virus Syndrome, 'Journal of Orthomolecular Medicine, 1989
게르마늄은 백내장의 진전을 늦춘다, Ge-132는 백내장의 진전을 늦췄으며, 백내장의 예방과 치료에도 좋은 효과를 보였다.Germanium slows the development of cataracts, Ge-132 slows the development of cataracts, and has been shown to be effective in the prevention and treatment of cataracts.
Source: Department of Biological Sciences, Oakland University,Source: Department of Biological Sciences, Oakland University,
Rochester, MI, Experimental Eye Research, August 1995.'Rochester, MI, Experimental Eye Research, August 1995. '
돌연변이성 인자의 억제제로써의 게르마늄Germanium as an inhibitor of mutagenic factor
많은 연구들이나 논문 등에서는 평상시 여러 가지 필수 영양소들을 골고루 섭취하기를 권한다. 특히 산화방지제, 비타민, 셀레늄 같은 영양소들은 잠재적이며 확실한 발암물질의 억제제이기 때문이다. 더 나아가서, 일정 양의 게르마늄을 꾸준히 복용하면 돌연변이성의 인자들이 억제되는 현상을 보이고 있다.Many studies and papers recommend a balanced diet of several essential nutrients. In particular, nutrients such as antioxidants, vitamins and selenium are potential and definitive carcinogen inhibitors. Furthermore, constant doses of germanium have been shown to inhibit mutagenic factors.
Source: Departrment of Oral Biology, Indiana University School of Dentistry, Indianapolis 46202. Mutation Research 1995 Aug., 335(1): 21-6Source: Departrment of Oral Biology, Indiana University School of Dentistry, Indianapolis 46202.Mutation Research 1995 Aug., 335 (1): 21-6
수술 후의 회복과 면역력을 높이는 게르마늄Germanium improves postoperative recovery and immunity
게르마늄은 수술 후의 탐식 세포들, 백혈구의 염색질들, 혈액 주위의 림프구들, 또 이들의 콘트롤 그룹 등의 거부 반응에 대한 면역학적인 반응의 증대와 인터페론 유도체로써의 효과가 입증되었다. 게르마늄의 그런 효과들은 수술 후 오랜 기간 지속되었으며, 이러한 결과들은 수술 후의 면역 거부 반응에 대한 동물들의 실험에서 게르마늄이 수술에 따른 면역 거부 반응의 여러 임상적인 증상들에 대하여 예방과 치료제로써의 효과가 있는 것으로 보여진다.Germanium has been shown to be effective as an interferon derivative and to enhance immunological response to rejection of post-operative phagocytes, leukocyte chromatin, lymphocytes around blood, and their control groups. Such effects of germanium persisted for a long time after surgery, and these results suggest that germanium is effective as a prophylactic and therapeutic agent for several clinical symptoms of postoperative immune rejection in animals. It is shown.
Source: Journal of Veterinary Medical Science, 1993 Oct., 55(5): 795-9.Source: Journal of Veterinary Medical Science, 1993 Oct., 55 (5): 795-9.
암, 악성종양에 대한 게르마늄의 효과Effect of Germanium on Cancer and Malignant Tumors
16-19세기의 많은 연구 논문, 임상보고들에 의하면 금속, 금속성분의 화합물들이 암, 백혈병 등의 치료에 유용하다는 언급들을 하고 있다. 그러나 불행스럽게도 무기화합물, 금속화합물 등에 의해서 악성종양, 암 등이 정복될 수 있다는 사실, 즉 그런 연구들이 1960년까지는 사람들에게 잊혀지고 있었다. 게르마늄을 포함한 많은 금속화합물들이 동물들의 실험과 사람의 임상실험에서 항 암과 악성종양 제거제로써의 커다란 효과를 보여주고 있다는 사실을...... Source: European Journal of Clinical Pharmacology, 1994, 47(1):1-16Many research papers and clinical reports from the 16th and 19th centuries have mentioned that metals and metal compounds are useful in the treatment of cancer and leukemia. Unfortunately, the fact that malignant tumors, cancers, etc. can be conquered by inorganic and metal compounds, that is, such studies were forgotten by people until 1960. Many metal compounds, including germanium, have shown great effects as anticancer and malignant tumor removers in animal and human clinical trials. Source: European Journal of Clinical Pharmacology, 1994, 47 ( 1): 1-16
동물 실험에서 유기 게르마늄은 혈압을 낮추는 작용과 많은 관계가 있으며, 이러한 유기 게르마늄의 혈압 강하 작용에 대한 연구 결과들은 1979년 일본 암 협회의 도꾜에서 있었던 제 38차 연례회의의 회의록 112페이지에 나와 있다. Source: The Clinical Report (Kiso to Rinsho, in Japanese) 7(1978):719In animal experiments, organic germanium has a lot to do with blood pressure-lowering effects, and the results of these studies on the blood pressure-lowering effects of organic germanium are found in page 112 of the 38th annual meeting of the 38th Annual Meeting in Tokyo, Japan. Source: The Clinical Report (Kiso to Rinsho, in Japanese) 7 (1978): 719
유기 게르마늄은 면역 반응 체계를 완전히 상실한 노쇠한 쥐들에게서 면역체계가 원 상태로 복구되는 것이 고찰되었다.Organic germanium has been considered to restore the immune system to its original state in older mice that have lost their immune response.
Source: International Archives of Allergy 63(1980): 338-339Source: International Archives of Allergy 63 (1980): 338-339
게르마늄은 Salmonella 구균에서 돌연변이유발에 대한 억제의 유도 작용으로써의 강력한 효능이 보여졌으며, 또한 박테리아에 대한 돌연변이유발 억제효과들이 주목되어 졌다. Source: Mutation Research 125 (1984): 145-151Germanium has been shown to be a potent potent inhibitor of mutagenesis in Salmonella cocci, and its effects on bacteria have been noted. Source: Mutation Research 125 (1984): 145-151
유기 게르마늄은 골다공증 환자들에게 뼈의 골절 방지는 물론 골다공증을 감소시키는 것으로 나타났다.Organic germanium has been shown to reduce osteoporosis as well as bone fracture in osteoporosis patients.
Source: Asai Germanium Research Institute, Tokyo, Japan, 1984.Source: Asai Germanium Research Institute, Tokyo, Japan, 1984.
게르마늄의 경구 투여는 인터페론 유도물질이 인체 내에서 조정되어 지는 긍정적인 효과들이 있었다.Oral administration of germanium has the positive effect that the interferon inducer is regulated in the body.
Source: Microbiology and Immunology 29, 1985:65-74.Source: Microbiology and Immunology 29, 1985: 65-74.
게르마늄 산화물(유기 게르마늄)은 인체 내에서 아주 중요한 인터페론 유도체로써 작용하는 것으로 나타났다. Source: Proceedings of the Japan Cancer Association Ⅱ, Annual Meeting, 1979, Page193.Germanium oxide (organic germanium) has been shown to act as an important interferon derivative in the human body. Source: Proceedings of the Japan Cancer Association II, Annual Meeting, 1979, Page 193.
유기 게르마늄은 종양, 악성 종양을 억제시킨다는 사실이 증명되었다.Organic germanium has been shown to inhibit tumors, malignant tumors.
Source: Cancer and Chemotherapy 6, in Japanese, (1968): 79-83.Source: Cancer and Chemotherapy 6, in Japanese, (1968): 79-83.
유기 게르마늄을 경구 투여한 경우는 생명이 현저하게 연장된다는 사실이 관찰되었다. Source: Gan To Kagaku Ryoho 12, December 1985:2345-51.Oral administration of organic germanium has been observed to significantly prolong life. Source: Gan To Kagaku Ryoho 12, December 1985: 2345-51.
유기 게르마늄이 강력한 종양, 악성 종양 억제제라는 것은, 유기 게르마늄의 인터페론 유도체로써의 작용과 관련이 있는 것으로 나타났다.The fact that organic germanium is a potent tumor and malignant tumor suppressor has been shown to be related to the function of organic germanium as an interferon derivative.
Source: Tohoku Journal of Experimental Medicine 146, May 1985:97Source: Tohoku Journal of Experimental Medicine 146, May 1985: 97
종양 억제에 대한 동물 실험 결과에서, 유기 게르마늄을 투여한 동물들에게서는 종양의 자라는 것이 멈췄으며 머지 않아 종양이 줄어들었다.In animal experiments on tumor suppression, tumors stopped growing in animals administered with organic germanium and the tumors soon contracted.
Source: Anticancer Research 6, March-April 1986:177-82.Source: Anticancer Research 6, March-April 1986: 177-82.
유기 게르마늄의 치료효과에 대한 동물 실험에서 종양을 확실하게 자라지 못하도록 하는 효과를 보였다. 이런 현상들은 인체 내의 탐식세포의 활발한 활동의 결과가 효과로 나타난 것으로 보여진다. (탐식 세포도 하나의 면역 시스템이며, 그들은 적을 공격한다)Animal experiments on the therapeutic effects of organic germanium have been shown to prevent tumor growth. These phenomena appear to be the result of the active activity of the phagocytic cells in the body. (The phagocytes are also one immune system, they attack the enemy)
Source: Gan To Kagaku Ryoho 12 November 1985:2122-8.Source: Gan To Kagaku Ryoho 12 November 1985: 2122-8.
유기 게르마늄이 종양억제제로써 항암제 키모떼라피(Chemotherapy)와 함께 사용되면 어떤 결과가 나올까에 대해서 연구하게 되었다. 결과들에 의하면 종양의 성장은 정지했으며, 종양의 전이억제 효과가 있었고, 생명의 생존기간이 연장되었고, 그리고 키모떼라피(Chemotherapy)의 부작용을 줄여 주었고 아울러 항암제 사용으로 줄어든 몸무게가 회복되었다.We have studied the results of organic germanium when used with chemotherapy, an anticancer drug, as a tumor suppressor. The results showed that tumor growth stopped, tumor metastasis was inhibited, life span was prolonged, the side effects of chemotherapy were reduced, and the weight lost to chemotherapy was restored.
Source: Gan To Kagaku Ryoho 13, Aug. 1986:2588-93.Source: Gan To Kagaku Ryoho 13, Aug. 1986: 2588-93.
암 종양, 백혈병세포를 접종시킨 동물들에게 유기 게르마늄을 복용하여 치료하는 실험을 하였다. 이 연구에서 유기 게르마늄은 암 세포를 직접 공격하는 것보다는 신체의 방어기능의 향상을 통한 효과가 있는 것으로 증명되었다. 즉 탐식 세포와 T-세포들을 포함 한 면역체계의 향상을 통한 작용으로 보인다. Source: Anticancer Research 5, Sep.-Oct. 1985:479-83Animals inoculated with cancer tumors and leukemia cells were treated with organic germanium. In this study, organic germanium has been shown to be effective in improving the body's defenses rather than directly attacking cancer cells. In other words, the immune system including phagocytic cells and T-cells seems to work. Source: Anticancer Research 5, Sep.-Oct. 1985: 479-83
혈압의 변화에 대항 동물실험에서, 정상적인 혈압의 동물들에게 게르마늄을 투여한 후의 관찰에서 정상적인 혈압 그대로 아무런 변화가 없었다. 그러나 혈압이 높은 동물들에게 투여한 후에는 게르마늄을 투여한지 7-10일에 놀랍게도 혈압이 정상 치로 돌아왔다. 이 효과는 게르마늄의 투여를 중단한 후로도 상당히 오랫동안 지속되었다.In animal experiments against changes in blood pressure, normal blood pressure was not changed as observed after germanium administration to animals with normal blood pressure. However, after the administration of animals with high blood pressure, the blood pressure was surprisingly returned to normal 7-10 days after Germanium administration. This effect persisted for quite some time after stopping the administration of germanium.
Source: Japan Experimental Research Institute, Tokyo, Japan.Source: Japan Experimental Research Institute, Tokyo, Japan.
유기 게르마늄은 경구투여와 주사에서 똑같이 모르핀과 같은 강력한 진통효과를 보여주었다. 게르마늄을 복용 또는 투여하면 인체 내에서 엔돌핀의 생산을 늘리고, 인체의 각 감각기관들이 진통작용을 늘리는 것으로 나타났다.Organic germanium has shown the same strong analgesic effect as morphine in oral and injection. Taking or administering germanium has been shown to increase the production of endorphins in the body and to increase the analgesic effects of each organ of the body.
Source: Journal of Pharmacological Dynamics 6(1983):814-820.Source: Journal of Pharmacological Dynamics 6 (1983): 814-820.
순도가 높은 유기게르마늄은 복용 후 인체 내에서 각종 임무를 마친 후 약 20-30시간 안에 인체 내에 있는 암 세포, 독소, 오염물질, 중금속 등을 붙들고 축적되는 것 없이 소변을 통해 인체에서 완전히 빠져나가므로 전혀 독성이 남지 않아 매우 안전하다.High-purity organic germanium completely escapes from the human body through urine without holding and accumulating cancer cells, toxins, contaminants, and heavy metals in the human body within about 20-30 hours after taking various tasks in the human body after taking them. It is very safe because there is no toxicity at all.
Source: Asai Germanium Research Institute, Tokyo, Japan.Source: Asai Germanium Research Institute, Tokyo, Japan.
기적의 원소, 푸른 빛의 마법사.... 미국 등 선진국에서는 셀레늄(Selenium)을 이렇게 부른다. 노화 방지-암 예방-면역기능 활성화 등에 효과가 있다고 해서다.Elements of miracles, wizards of blue light .. In developed countries such as the United States, selenium is called. It is said to be effective for anti-aging, cancer prevention, and immune function activation.
원소기호가 Se인 초기에 독성이 있는 원소여서 적당한 사용처를 찾지 못해 오랫동안 철저하게 잊혀진 원소로 존재했다. 독성에 관한 가장 오래된 기록은 13세기 마르코 폴로의 [동방견문록]에서 찾아볼 수 있으며 1860년에는 사우스다코타 지역에 주재하던 군대의 군의관이 말에서 셀레늄 중독 증상을 보고한 기록이 있다. 셀레늄을 과잉섭취하면서 털과 발굽이 빠지는 치명적인 중상이 나타난 것이다. 하지만 1960년대 이후 결핍과 관련된 연구가 활발해지면서 관심을 끌기 시작했다. 이런 과정 중 1973년에는 셀레늄이 동물 체내에서 항산화작용(일종의 노화 방지)을 하는 효소인 글루타티온 퍼옥시다제의 필수 구성 성분임이 밝혀졌다. 이후 1978년에는 세계보건기구(WHO)가 셀레늄을 필수 영양소로 인정하고 50~200μg을 1일 권장량으로 정했다. 선진국에서 불고 있는 셀레늄 열풍이 국내에도 상륙할 조짐을 보이고 있다. 장류식품-닭고기 등에 셀레늄 성분을 강화한 제품이 속속 나오고 있고, 제약회사에서도 종합비타민제에 셀레늄 첨가를 서두르고 있다. 최근에는 사스(SARS-중증급성호흡기증후군)의 원인으로 셀레늄 결핍이 지목되면서 전세계적으로 셀레늄에 대한 관심이 부쩍 높아졌다.In the early period when the element symbol was Se, it was a toxic element, so it existed as a long forgotten element because it could not find a suitable use. The oldest record of toxicity can be found in the 13th-century Marco Polo's Eastern Gate, and in 1860, a military surgeon in South Dakota reported horses showing selenium poisoning. Excessive intake of selenium resulted in fatal injuries that caused hair and hoof to fall out. However, since the 1960s, research on deficiency has become active and has attracted interest. In 1973, selenium was found to be an essential component of glutathione peroxidase, an enzyme that acts as an antioxidant in the body. In 1978, the World Health Organization (WHO) recognized selenium as an essential nutrient and set 50-200 μg as the recommended daily dose. Selenium fever blowing in developed countries is showing signs of landing in Korea. Products that are fortified with selenium are being introduced one after another, and pharmaceutical companies are also hastening to add selenium to multivitamins. In recent years, selenium deficiency has been identified as a cause of SARS, and interest in selenium has increased significantly around the world.
이에 본 발명자들은 출원번호: 10-2003-0089903, 10-2004-0042371로 생산된 식물류의 파우더와 출원번호 : 10-2004-0019493의 방법으로 제조된 효소를 이용하였으며, 특히 게르마늄은 게르마늄을 함유하는 모든 화합물 게르마늄-효모 복합체, Ge132, 킬레이팅된 유기게르마늄등을 사용할 수 있으며, 셀레늄의 경우 Na2SeO3, Na2SeO4등 무기태의 셀레늄과 셀레늄-효모 복합체, 킬레이팅된 유기 셀레늄이 함유된 물질등을 사용할 수 있지만, 본 발명에서는 바람직하게 출원된 방법으로 재배된 게르마늄과 셀레늄을 함유한 식물과 분말, 효소을 사용하여, 인체에 흡수율이 높으며 인체 이용성이 좋은 안전한 유기게르마늄과 셀레늄을 함유하는 장류식품(간장,된장, 고추장등)류를 생산하여 본 발명을 완성하였다.Therefore, the present inventors used the powder of plants produced by the application number: 10-2003-0089903, 10-2004-0042371 and the enzyme prepared by the method of the application number: 10-2004-0019493, in particular, germanium containing germanium All compounds can use germanium- yeast complexes, Ge132, chelated organic germanium, etc.In the case of selenium, inorganic substances such as Na2SeO3, Na2SeO4 and selenium-yeast complexes, and materials containing chelated organic selenium can be used. In the present invention, using a plant and powder containing germanium and selenium, preferably cultivated in the filed method, enzymes, foods containing soybeans (soy sauce, soybean paste, Kochujang, etc.) was produced to complete the present invention.
따라서, 본 발명의 목적은 장류식품로 제조된 식품, 장류식품이 첨가된 제품에 셀레늄과 게르마늄 함유 성분을 먹고 성장한 채소와 과일에 함유한 셀레늄과 게르마늄을 함유한(출원번호: 10-2003-0089903, 10-2004-0042371) 식물의 재배방법으로 생산된 식물의 녹즙과 과즙, 건조된 파우더와 출원번호 : 10-2004-0019493의 방법으로 제조된 효소를 이용하여 발효된 장류식품에 양념으로 첨가하여 체내 흡수율이 높고 인체 이용성이 좋은 안전한 게르마늄과 셀레늄이 함유된 고추장, 된장, 간장등 장류 숙성식품을 제공하는데 있다.Accordingly, an object of the present invention is to include selenium and germanium contained in vegetables and fruits grown by eating selenium and germanium-containing ingredients in foods prepared with the enteric foods, foods added to the enteric foods (application number: 10-2003-0089903 , 10-2004-0042371) By adding to the fermented enteric foods as a seasoning by using the green juice and juice of the plant produced by the method of plant cultivation, dried powder and enzyme prepared by the method of Application No. 10-2004-0019493 It is to provide fermented aging foods such as red pepper paste, doenjang and soy sauce containing germanium and selenium, which have high absorption rate and good human availability.
상기와 같은 본 발명의 목적을 달성하기 위하여 게르마늄은 유기화된 모든 화합물게르마늄-효모 복합체, Ge132, 킬레이팅된 유기 게르마늄과 셀레늄의 경우 Na2SeO3, Na2SeO4, 셀레늄-효모 복합체, 킬레이팅된 유기 셀레늄이 함유된 물질등을 사용할 수 있지만, 본 발명에서는 바람직하게 출원번호 : 10-2003-0089903, 10-2004-0042371로 생산된 식물류의 분말과 출원번호 : 10-2004-0019493의 방법으로 제조된 효소를 사용하여, 인체에 흡수율이 높으며 인체 이용성이 좋은 안전한 유기게르마늄과 셀레늄을 함유하는 장류식품, 제품을 생산하는데 성공하여 본 발명을 완성하였다.In order to achieve the object of the present invention, germanium is an organic compound of all compounds germanium- yeast complex, Ge132, chelated organic germanium and selenium Na2SeO3, Na2SeO4, selenium-yeast complex, chelated organic selenium containing Although a substance and the like can be used, in the present invention, it is preferable to use powders of plants produced by the application Nos. 10-2003-0089903 and 10-2004-0042371 and enzymes prepared by the method of the application No. 10-2004-0019493. The present invention has been successfully completed to produce food products and products containing organic germanium and selenium, which have high absorption rate and good human availability.
본 발명에 따른 상기 게르마늄과 셀레늄 함유 장류식품 및 첨가 제품류의 제조방법은,The method of manufacturing the germanium and selenium-containing enteric foods and added products according to the present invention,
(1) 출원번호 : 10-2003-0089903, 10-2004-0042371의 방법대로 식물류를 재배하는 단계 및:(1) cultivating the plant according to the method of Application No. 10-2003-0089903, 10-2004-0042371, and:
(2) 재배된 식물을 세척, 절단, 건조, 파우더를 제조하는 단계 및;(2) washing, cutting, drying, and preparing powders of the grown plants;
(3) 양념 및 게르마늄, 셀레늄 함유 채소나 건조된 분말을 숙성된 장류식품 제품에 적당량을 첨가 교반하는 단계 및 포장하는 단계로 이루어진다.(3) seasoning and adding germanium and selenium-containing vegetables or dried powder to an aged fermented food product by adding an appropriate amount, stirring and packaging.
이하, 본 발명을 실시예에 의해 설명하지만, 이들에 의해 본 발명의 범위가 제한되는 것은 아니다.Hereinafter, although an Example demonstrates this invention, the scope of the present invention is not restrict | limited by these.
이하, 실시예에 따라 재배되는 본 발명에 대해 구체적으로 설명한다.Hereinafter, the present invention cultivated according to the embodiment will be described in detail.
실시예 1:Example 1:
출원번호 : 10-2003-0089903, 10-2004-0042371의 방법대로 10~10000㎍/kg의 셀레늄, 게르마늄을 함유한 식물류를 재배하는 단계와,Cultivating plants containing 10 to 10,000 g / kg of selenium and germanium according to the method of Application No. 10-2003-0089903, 10-2004-0042371,
출원번호 : 10-2004-0019493의 방법대로 1㎍ 이상의 셀레늄이 포함된 식물의 발효 효소를 제조하는 단계와, 재배된 식물을 세척, 절단, 건조, 파우더를 제조하는 단계와, 식물과 효소에 함유된 셀레늄의 농도를 계산하여 숙성된 장류 식품류에 양념과 함께 적당량을 첨가, 버무리는 단계와, 포장하는 단계로 이루어지며,Preparing fermentation enzymes of plants containing 1 µg or more of selenium, washing, cutting, drying, and preparing powders, and containing them in plants and enzymes according to the method of Application No. 10-2004-0019493. Calculate the concentration of selenium and add the appropriate amount with seasoning and seasoning to the aged foods, and mix and pack
실시예 2:Example 2:
Ge132, 유기 게르마늄 함유 물질과 Na2SeO3, Na2SeO4의 무기태 셀레늄 및 1㎍ 이상의 유기 셀레늄이 함유된 물질을 장류식품의 원 재료인 생선과 첨가, 교반하여 3개월 이상 숙성, 제조하는 단계로 이루어진다.Ge132, an organic germanium-containing material and inorganic selenium of Na 2 SeO 3, Na 2 SeO 4 and a substance containing 1 μg or more of organic selenium are added with fish, which is a raw material of the enteric food, and stirred, and aged for 3 months or more.
본 발명이 있기 전까지는 셀레늄과 게르마늄의 성분을 섭취하기 위해서는 각각 따로 섭취하여야 했으나 본 발명에 따라 제조된 장류식품은 제조하는 공정대로 셀레늄과 게르마늄의 성분을 각각 따로 섭취하거나 동시에 첨가 제조하여 항암 항 산화효과가 있는 게르마늄, 셀레늄을 발명된 식물류와 혼합하여 독성이 없고 치료 및 예방효과가 있는 흡수율이 높은 인체에 유익한 게르마늄과 셀레늄을 자연스럽게 있는 섭취할 수 있게되었다.Until the present invention, in order to ingest the ingredients of selenium and germanium, each had to be ingested separately, but the foods prepared in accordance with the present invention is the anti-cancer antioxidant by ingesting or separately adding the ingredients of selenium and germanium according to the manufacturing process, respectively. By combining effective germanium and selenium with the invented plants, it is possible to naturally ingest germanium and selenium which is beneficial to the human body, which is non-toxic and has a high absorption rate, which is therapeutic and preventive.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040057011A KR20040072534A (en) | 2004-07-21 | 2004-07-21 | Production of fermented soy products containing germanium and selenium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040057011A KR20040072534A (en) | 2004-07-21 | 2004-07-21 | Production of fermented soy products containing germanium and selenium |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20040072534A true KR20040072534A (en) | 2004-08-18 |
Family
ID=37360053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040057011A KR20040072534A (en) | 2004-07-21 | 2004-07-21 | Production of fermented soy products containing germanium and selenium |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20040072534A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100722971B1 (en) * | 2006-06-05 | 2007-05-30 | 안영환 | A method for manufacturing a soybean paste including codonopsis lanceolata and a soybean paste thereof |
KR102147880B1 (en) * | 2020-05-01 | 2020-08-26 | 에스지바이오식품 주식회사 | Manufacturing method of functional ginseng toenjang fused with zinc and selenium |
KR102147882B1 (en) * | 2020-05-01 | 2020-08-26 | 에스지바이오식품 주식회사 | Manufacturing method of functional ginseng kochujang fused with zinc and selenium |
-
2004
- 2004-07-21 KR KR1020040057011A patent/KR20040072534A/en not_active Application Discontinuation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100722971B1 (en) * | 2006-06-05 | 2007-05-30 | 안영환 | A method for manufacturing a soybean paste including codonopsis lanceolata and a soybean paste thereof |
KR102147880B1 (en) * | 2020-05-01 | 2020-08-26 | 에스지바이오식품 주식회사 | Manufacturing method of functional ginseng toenjang fused with zinc and selenium |
KR102147882B1 (en) * | 2020-05-01 | 2020-08-26 | 에스지바이오식품 주식회사 | Manufacturing method of functional ginseng kochujang fused with zinc and selenium |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ghaeni et al. | Review for application and medicine effects of Spirulina, microalgae | |
KR20040071086A (en) | Cultivation of plants containing simultaneously containing germanium and selenium | |
Singh et al. | Moringa olifera: nutrient dense food source and world’s most useful plant to ensure nutritional security, good health and eradication of malnutrition | |
KR101380632B1 (en) | Kimchi for improvement of skin and manufacturing method thereof | |
KR20050012855A (en) | Method for preparing animal fodder containing organic germanium and organic selenium having no toxicity and antioxidative and anticancer activity | |
KR20050010990A (en) | Production of germinated brown rice containing germanium and selenium by soaking rice in water containing germanium and selenium and germinating | |
KR101380633B1 (en) | Kimchi for anti-aging and manufacturing method thereof | |
KR20050027238A (en) | Cultivation method of sprout vegetables containing selenium and germanium | |
RU2681104C1 (en) | Cereal bat for feeding workers working with chrome and chrome-containing compounds | |
KR20040075796A (en) | Production of milk product containing germanium and selenium | |
KR20040072534A (en) | Production of fermented soy products containing germanium and selenium | |
KR20040096468A (en) | Method for preparing fermented soybeans containing selenium and germanium to improve health of human | |
KR20050032547A (en) | Manufacturing method of porridge containing vegetable organic selenium and germanium | |
KR20040066752A (en) | Method for preparing roast meat(bulgogi) and spices thereof containing germanium and selenium | |
Abera et al. | The Significance of Garlic (Allium sativum L.) on the Livelihood of the Local Community | |
KR20040071089A (en) | Cultivation of mulberry tree containing selenium and germanium | |
KR101380637B1 (en) | Kimchi with hypoglycemic effect and manufacturing method thereof | |
KR20040070130A (en) | Production of pickled seafoods juice containing germanium and selenium | |
KR20050032050A (en) | Culture method of chlorella containing selenium and germanium | |
KR20160096295A (en) | Crickets for improved anti-cancer and food compositions comprising the same | |
KR102251614B1 (en) | process of culturing | |
KR20040070131A (en) | Production of boiled fish paste containing germanium and selenium | |
KR20050032077A (en) | Manufacturing method of sandwich containing vegetable organic selenium and germanium | |
KR20040052748A (en) | Method for cultivating strawberry containing germanium | |
KR20050032051A (en) | Method for preparing gimbap containing vegetable organic selenium and germanium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Withdrawal due to no request for examination |